Technical Analysis for CERT - Certara, Inc.

Grade Last Price % Change Price Change
C 18.27 -1.03% -0.19
CERT closed down 1.03 percent on Monday, March 18, 2024, on 85 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
NR7 Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Outside Day Range Expansion -4.65%
Overbought Stochastic Strength -4.65%
Gapped Down Weakness -4.65%
Overbought Stochastic Strength -3.03%
Down 3 Days in a Row Weakness -3.03%
Upper Bollinger Band Walk Strength -3.94%
Overbought Stochastic Strength -3.94%

   Recent Intraday Alerts

Alert Time
Up 1% about 8 hours ago
60 Minute Opening Range Breakout about 8 hours ago
Possible NR7 about 9 hours ago
60 Minute Opening Range Breakdown about 12 hours ago
Fell Below Previous Day's Low about 12 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Certara, Inc. Description

Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. The company serves biopharmaceutical companies and academic institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, and Australia. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Health Sciences Pharmacy Medication Drug Discovery Pharmacology Drug Development Pharmaceutical Sciences Systems Biology Medical Communications

Is CERT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.95
52 Week Low 11.81
Average Volume 546,338
200-Day Moving Average 16.40
50-Day Moving Average 17.23
20-Day Moving Average 18.11
10-Day Moving Average 18.89
Average True Range 0.66
RSI (14) 52.38
ADX 29.91
+DI 23.66
-DI 13.51
Chandelier Exit (Long, 3 ATRs) 17.88
Chandelier Exit (Short, 3 ATRs) 18.19
Upper Bollinger Bands 20.00
Lower Bollinger Band 16.21
Percent B (%b) 0.54
BandWidth 20.90
MACD Line 0.46
MACD Signal Line 0.51
MACD Histogram -0.0497
Fundamentals Value
Market Cap 2.92 Billion
Num Shares 160 Million
EPS -0.22
Price-to-Earnings (P/E) Ratio -83.05
Price-to-Sales 8.05
Price-to-Book 2.56
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.89
Resistance 3 (R3) 18.94 18.80 18.78
Resistance 2 (R2) 18.80 18.64 18.77 18.75
Resistance 1 (R1) 18.53 18.54 18.46 18.48 18.71
Pivot Point 18.39 18.39 18.35 18.36 18.39
Support 1 (S1) 18.12 18.23 18.05 18.07 17.83
Support 2 (S2) 17.98 18.13 17.95 17.79
Support 3 (S3) 17.71 17.98 17.76
Support 4 (S4) 17.66